Pfizer’s Bourla Defends Cancer Drug Pricing

“We should not discourage innovation right now,” Pfizer’s Group President of Vaccines, Oncology and Consumer Healthcare Albert Bourla said during a media briefing at the company headquarters. https://www.pharmamedtechbi.com/Publications/The-Pink-Sheet-Daily/2015/9/22/Pfizers-Bourla-Defends-Cancer-Drug-Pricing?elsca1=pdly&elsca2=rss&elsca3=